Serina Therapeutics, Inc. Common Stock SER 深 沪
已收盘 10-17 16:00:00 美东时间
4.808
-0.082
-1.68%
华盛通- 最 高4.8785
- 今 开4.85
- 成交量 1.84万股
- 最 低 4.7601
- 昨 收 4.89
- 总市值 4275.27万
- 52周最高 7.92
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.81
- 委 比 0.00%
- 总股本 889.20万
- 历史最高 209.2615
- 量 比 0.76
- 振 幅 2.42%
- 历史最低 4.10
- 每 手 1
- 风险率 0.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Regions Financial Corporation DEPOSITARY SHS REP 1/40TH PERP PFD SER E declares $0.2781 dividend
Regions Financial Corporation DEPOSITARY SHS REP 1/40TH PERP PFD SER E (RF.PR.E) declared $0.2781/share quarterly dividend, in line with previous. Payable Dec. 15; for shareholders of record Dec. 1; e...
10-17 01:47
大冶特钢，“卓越供应商”
（来源：特钢技术） 10月14日，大冶特殊钢有限公司迎来重要时刻——全球工程机械巨头卡特彼勒全球采购总监Ernie Reyes率亚太区团队到访，为其颁发“IE...
10-16 14:14
消费板块获资金持续关注！消费ETF(159928)盘中获净申购超3.8亿份，规模突破205亿元！老铺黄金涨超9%，港股通消费50ETF(159268)大涨超2%
今日（10.15），大消费再度飘红，消费ETF（159928）小涨0.24%，盘中成交额超7.5亿元。资金面上，消费ETF（159928）此前两日大举“吸金”近...
10-15 14:27
Geron's COO Andrew Grethlein To Depart On October 15, 2025
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several
10-14 04:42
Strategy acquires 220 bitcoins for $27.2M in past week
Bitcoin treasury company Strategy (NASDAQ:MSTR) announced on Monday an acquisition of 220 bitcoins for $27.2M during the week of October 6 to October 12. The cryptocurrency was bought for an average p...
10-13 20:22
Servotech Secures 2.58MW Solar Project with South Eastern Railway
Servotech Power Systems Ltd. ( ($IN:SERVOTECH) ) just unveiled an announcement....
10-13 12:42
企业营销变局：传统搜索死亡，流量分配被AI重新定义？
随着ChatGPT、DeepSeek这些AI平台的爆炸性崛起，像谷歌的全球搜索市场份额从2015年以来首次跌破90%。 我们国内的百度其实更惨，因为有着短视频直...
10-12 06:29
泡泡玛特盘中涨超4% 大摩看好公司销售势头持续
泡泡玛特（09992）盘中涨超4%，截至发稿，股价上涨2.82%，现报269.80港元，成交额28.64亿港元。 10月10日，抢泡泡玛特相关话题冲上微博热...
10-10 11:21
Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors
Serina Therapeutics launched a corporate communications platform to provide timely updates on its programs, including the upcoming Phase 1b trial of SER-252 for Parkinson’s disease. The platform offers digital updates, educational resources, multimedia content, and engagement opportunities. SER-252, developed using the POZ Platform, aims to reduce motor fluctuations in Parkinson’s patients through continuous dopaminergic stimulation.
10-08 15:00
Serina Therapeutics Secures $5M for Parkinson’s Trial
Serina Therapeutics ( ($SER) ) has provided an update. On October 6, 2025, Seri...
10-07 04:29
